刘俊呈 司春婴 王贺 解金红 关怀敏

    [摘要] 支架内再狭窄是冠状动脉粥样硬化患者经皮冠状动脉介入术后最常见的并发症，其确切的发病机制尚未完全清楚。药物涂层球囊的出现为冠状动脉介入治疗提供了新的方法，然而，其临床应用和预后评估仍缺乏共识，尤其是对冠脉支架内再狭窄中的应用效果存在争议。本文论述了药物涂层球囊在冠脉支架内再狭窄治疗的临床应用进展。

    [关键词] 支架内再狭窄;经皮冠状动脉介入术;药物涂层球囊;冠状动脉

    [中图分类号] R654.2? ? ? ? ? [文献标识码] A? ? ? ? ? [文章编号] 1673-7210(2019)09(b)-0033-04

    Progress in the application of drug-coated balloon in the treatment of in-stent restenosis

    LIU Juncheng1? ?SI Chunying2? ?WANG He2? ?XIE Jinhong2▲? ?GUAN Huaimin2▲

    1.The First Clinical Medical College， He′nan University of Chinese Medicine， He′nan Province， Zhengzhou? ?450000， China; 2.Ward 3， Cardiovascular Medicine Department， the First Affiliated Hospital of He′nan University of Chinese Medicine， He′nan Province， Zhengzhou? ? 450000， China

    [Abstract] After percutaneous coronary intervention， in-stent restenosis is the most common complication in patients with coronary atherosclerosis， and its exact pathogenesis is unclear. The emergence of drug-eluting balloon provids a new method for coronary artery intervention treatment. However， there is still a lack of consensus on clinical application and prognostic evaluation ......